M&A

Perrigo CEO says no easy path for Mylan to acquire company
Yahoo/Reuters
Wed, 08/5/15 - 05:00 pm
Perrigo
Mylan Labs
M&A
These 2 Catalysts Helped Push Celgene's Market Value Over $100 Billion in July
Motley Fool
Wed, 08/5/15 - 10:24 am
Celgene
Receptos
M&A
Teva’s Just the Start as More Generic Drugmakers Poised to Merge
Bloomberg
Wed, 08/5/15 - 09:34 am
Teva Pharmaceutical
Allergan
M&A
generics
Lannett
Impax Labs
Sagent Pharmaceuticals
Shire’s Baxalta bid: Poison pill or antidote?
CNBC
Wed, 08/5/15 - 09:31 am
Shire
Baxalta
M&A
poison pill
Pfizer wins EU approval for $15 billion Hospira buy
Yahoo/Reuters
Tue, 08/4/15 - 06:05 pm
Pfizer
Europe
Hospira
M&A
Horizon and Depomed Sue Each Other Over Takeover Tactics
TheStreet.com
Tue, 08/4/15 - 06:04 pm
Horizon Pharma
Depomed
M&A
Baxalta responds to a frustrated Shire: The answer is still 'no'
Fierce Biotech
Tue, 08/4/15 - 05:55 pm
Shire
M&A
Baxalta
3 Potential Huge Takeover Targets in Biotech
24/7 Wall St
Tue, 08/4/15 - 05:53 pm
biotech
M&A
Biogen
Alexion
Vertex Pharmaceuticals
Celgene’s Bid for Receptos Could Be Topped
Barron's
Tue, 08/4/15 - 08:27 am
Celgene
Receptos
M&A
Biogen Inc : Acquirer Or To-Be-Acquired?
Bidness, ETC
Tue, 08/4/15 - 08:25 am
Biogen
M&A
Alexion
Vertex Pharmaceuticals
Shire Proposes Combination With Baxalta to Create the Leading Global Biotech Company Focused on Rare Diseases
Yahoo
Tue, 08/4/15 - 08:20 am
Shire
Baxalta
M&A
Is the Cigna–Anthem Merger a Setup?
Yahoo/Market Realist
Tue, 08/4/15 - 08:18 am
Cigna
Anthem
M&A
insurers
Horizon asks for Depomed vote, files lawsuit in hostile bid
Yahoo/AP
Mon, 08/3/15 - 10:21 am
Horizon Pharma
Depomed
M&A
How Allergan Stands To Gain From Teva Pharmaceutical Industries Ltd (ADR) Deal
Bidness, ETC
Mon, 08/3/15 - 09:03 am
Allergan
Teva Pharmaceutical
M&A
generics
Shire chief Ornskov bets $300M on another eye drug bolt-on buyout
Fierce Biotech
Mon, 08/3/15 - 08:53 am
Shire
Flemming Ornskov
M&A
FST-100
ophthalmology
Amendia buys Custom Spine
Mass Device
Fri, 07/31/15 - 03:14 pm
devices
Amendia
Custom Spine
M&A
With solid Q2, Sanofi CEO says M&A could be part of growth strategy
Fierce Pharma
Fri, 07/31/15 - 11:04 am
Sanofi
M&A
Pharma CEOs
Olivier Brandicourt
Mylan Might Be Better Off Without Perrigo
Seeking Alpha
Fri, 07/31/15 - 11:02 am
Mylan Labs
Perrigo
M&A
Sequent Aims to Lure Buyers in $30 Billion Veterinary Market
Bloomberg
Thu, 07/30/15 - 10:24 am
animal health
M&A
Sequent Group
India
Depomed rejects Horizon Pharma's latest bid
Yahoo/Reuters
Thu, 07/30/15 - 10:21 am
Depomed
M&A
Horizon Pharma

Pages